• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

BD names new president of Pharmacy Automation biz

July 1, 2026 By Sean Whooley

Matt Sassone BD Pharmacy Automation
Matt Sassone [Image courtesy of BD]
BD (NYSE:BDX) announced today that it appointed Matthew Sassone as worldwide president of its Pharmacy Automation business.

Sassone now leads the global business within the BD Medication Management Solutions business unit. His appointment goes into effect immediately.

In the role, Sassone’s responsibilities include driving global strategy, performance and growth for Pharmacy Automation as part of Connected Care. His focus centers on advancing innovation, expanding market presence and delivering solutions that address the evolving needs across healthcare settings. That includes retail and health system pharmacies, according to the Franklin Lakes, New Jersey-based company.

Sassone joins BD from Tristel a global infection prevention company, where he served as CEO. The company says he delivered strong revenue and profit growth at Tristel. Before Tristel, he held senior leadership roles across leading medical technology companies. Those include Smiths Medical, Getinge and Masimo, where he led global marketing and commercial strategy.

BD says Sassone has more than 20 years of experience in medtech, diagnostics and hospital automation.

Sassone will be based out of the company’s Pharmacy Automation headquarters in Durham, North Carolina. He reports to Bilal Muhsin, EVP and president of BD Connected Care.

“Matt is a highly accomplished global healthcare executive with a strong track record of translating innovation into real-world impact,” said Muhsin. “His deep understanding of connected technologies and data-driven solutions will be instrumental as we continue to evolve our Pharmacy Automation business and deliver advanced robotics with more intelligent, integrated capabilities for our customers.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Personnel, Pharmaceuticals, Technology Tagged With: BD, Personnel Moves

IN CASE YOU MISSED IT

  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS